Owners of Quest Diagnostics (NYSE: DGX) shares as of market close today will be eligible for a dividend of 30 cents per share. At a price of $56.41 as of 9:35 a.m. ET, the dividend yield is 2.1%. The average volume for Quest Diagnostics has been 1.3 million shares per day over the past 30 days. Quest Diagnostics has a market cap of $8.9 billion and is part of the health services industry. Shares are down 1.7% year to date as of the close of trading on Tuesday. EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys dividend stocks that have the potential for a 3% to 4% yield and 10% growth. Get his best picks for less than $50/year. Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. The company has a P/E ratio of 14.39. Currently there is 1 analyst that rates Quest Diagnostics a buy, 2 analysts rate it a sell, and 14 rate it a hold. TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Quest Diagnostics Ratings Report now.